![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/cali-biosciences-announces-publication-of-successful-phase-2-study-results-in-hernia-302151218.html
https://www.prnewswire.com/news-releases/cali-biosciences-initiates-second-phase-iii-study-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-and-presents-consistent-and-predictable-pk-results-across-multiple-surgeries-301841948.html
https://www.prnewswire.com/news-releases/cali-biosciences-initiates-phase-iii-studies-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-301801255.html